Found: 9
Select item for more details and to access through your institution.
Efficacy and safety of dapagliflozin plus saxagliptin versus insulin glargine over 52 weeks as add‐on to metformin with or without sulphonylurea in patients with type 2 diabetes: A randomized, parallel‐design, open‐label, Phase 3 trial
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 6, p. 957, doi. 10.1111/dom.13981
- By:
- Publication type:
- Article
Model‐based characterization of the relationship between dapagliflozin systemic exposure and HbA1c response in patients with type 1 diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1381, doi. 10.1111/dom.13664
- By:
- Publication type:
- Article
Efficacy and safety of dapagliflozin in addition to insulin therapy in Japanese patients with type 2 diabetes: Results of the interim analysis of 16-week double-blind treatment period.
- Published in:
- Journal of Diabetes Investigation, 2016, v. 7, n. 4, p. 555, doi. 10.1111/jdi.12453
- By:
- Publication type:
- Article
Dapagliflozin Plus Saxagliptin Add-on Therapy Compared With Insulin in Patients With Type 2 Diabetes Poorly Controlled by Metformin With or Without Sulfonylurea Therapy: A Randomized Clinical Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Randomized, Double-Blind, Phase 3 Trial of Triple Therapy With Dapagliflozin Add-on to Saxagliptin Plus Metformin in Type 2 Diabetes.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Randomized, Double-Blind Trial of Triple Therapy With Saxagliptin Add-on to Dapagliflozin Plus Metformin in Patients With Type 2 Diabetes.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Safety, Pharmacokinetics and Pharmacodynamics of the Selective Glucocorticoid Receptor Modulator AZD5423 after Inhalation in Healthy Volunteers.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2016, v. 119, n. 6, p. 574, doi. 10.1111/bcpt.12621
- By:
- Publication type:
- Article
Metabolite profiling reveals normal metabolic control in carriers of mutations in the glucokinase gene (MODY2).
- Published in:
- 2013
- By:
- Publication type:
- journal article
Metabolite Profiling Reveals Normal Metabolic Control in Carriers of Mutations in the Glucokinase Gene (MODY2).
- Published in:
- Diabetes, 2013, v. 62, n. 2, p. 653, doi. 10.2337/db12-0827
- By:
- Publication type:
- Article